Seeking Alpha

ACTCD
  ADVANCED CELL TECH NEW - OTCQB

9/16/2014, 10:52 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
ACTCD vs. ETF Alternatives
Company Description
Advanced Cell Technology ("ACT"; ACTC), is a biotechnology company developing cellular therapies for treating diseases that impact millions of people worldwide. <br />Helmed by Chairman and CEO Gary Rabin, ACT is currently conducting the only human embryonic stem cell (hESC)-based clinical... More